Skip to content

Lyric4 Outcomes Evaluation

Evaluation of Daily- and Extended-wear Hearing Instruments

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06169683
Enrollment
28
Registered
2023-12-13
Start date
2023-11-10
Completion date
2024-01-31
Last updated
2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Keywords

hearing loss

Brief summary

The goal of this clinical investigation is to obtain feedback on Lyric4 device updates within a cohort of experienced adult Lyric hearing instrument users. The main question it aims to answer is: • Do device updates cause a change in Lyric patient experience? Participants will be asked to complete questionnaires about their past experience with Lyric, as well as their experience with Lyric during the study period. They will also be asked to undergo aided audiometric testing with Lyric devices.

Interventions

DEVICELyric4

Lyric4 Hearing instrument use

Sponsors

Sonova AG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Experience with Lyric hearing instruments * Willingness to travel to the study site and complete study procedures * Adults, age 18 or older * Fluency with English (written/spoken)

Exclusion criteria

* No Lyric hearing instrument experience * Ear health issues preventing Lyric fitting or requiring medical clearance prior to fitting * Difficulty reading when corrected for vision loss

Design outcomes

Primary

MeasureTime frame
Aided Audiometric TestingFrom enrollment to the end of the study period, approximately one month.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026